Australia Covid-19 Vaccine Development Tools Market Size & Outlook
Australia covid-19 vaccine development tools market, 2020-2028 (US$M)
Related Markets
Australia covid-19 vaccine development tools market highlights
- The Australia covid-19 vaccine development tools market generated a revenue of USD 896.5 million in 2020 and is expected to reach USD 1,802.4 million by 2028.
- The Australia market is expected to grow at a CAGR of 9.1% from 2021 to 2028.
- In terms of segment, laboratory technologies was the largest revenue generating technologies in 2020.
- Online Technologies is the most lucrative technologies segment registering the fastest growth during the forecast period.
Covid-19 vaccine development tools market data book summary
| Market revenue in 2020 | USD 896.5 million |
| Market revenue in 2028 | USD 1,802.4 million |
| Growth rate | 9.1% (CAGR from 2020 to 2028) |
| Largest segment | Laboratory technologies |
| Fastest growing segment | Online Technologies |
| Historical data | 2020 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Laboratory Technologies, Online Technologies |
| Key market players worldwide | Thermo Fisher Scientific Inc, Pfizer Inc, Sartorius AG, Stemcell Holdings Inc Ordinary Shares, Illumina Inc, Agilent Technologies Inc, Bio-Rad Laboratories Inc, Danaher Corp, Merck KGaA, Qiagen NV, Shimadzu Corp, Eurofins Scientific SE, Charles River Laboratories International Inc, Takara Bio Inc, Olympus Corp, Avantor Inc, Aurora Innovation Inc Class A, Standard BioTools Inc, Celerion, Cole-Parmer, Hartford Schroders International Stk I, Revvity Inc, Fluidigm Corporation, Polyplus-transfection, Hamilton Lane Inc Class A |
Other key industry trends
- In terms of revenue, Australia accounted for 5.6% of the global covid-19 vaccine development tools market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
- In Asia Pacific, China covid-19 vaccine development tools market is projected to lead the regional market in terms of revenue in 2028.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 955.5 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
COVID-19 Vaccine Development Tools Market Scope
COVID-19 Vaccine Development Tools Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia covid-19 vaccine development tools market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to covid-19 vaccine development tools market will help companies and investors design strategic landscapes.
Laboratory technologies was the largest segment with a revenue share of 95.62% in 2020. Horizon Databook has segmented the Australia covid-19 vaccine development tools market based on laboratory technologies, online technologies covering the revenue growth of each sub-segment from 2020 to 2028.
Presence of academic & research institutes in the region is a major factor fueling growth of COVID-19 vaccine development tools. For instance, CSIRO, Australia’s national science agency, was allotted 0.72 million by the Australian government under stem cell therapies mission for facilitating rapid implementation of existing drugs for clinical use against the virus.
The process researchers employed was to rapidly screen the existing drugs, advance those drugs that can be used for treatment, and apply for FDA-approved drug candidates to progress with human trials within a year.
The initiative was a collaboration between Barwon Health, CSIRO, and Deakin University. Similarly, the University of Queensland collaborated with CSL and CEPI to enhance development, manufacturing, and distribution of a COVID-19 vaccine candidate.
Reasons to subscribe to Australia covid-19 vaccine development tools market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia covid-19 vaccine development tools market databook
-
Our clientele includes a mix of covid-19 vaccine development tools market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia covid-19 vaccine development tools market , including forecasts for subscribers. This country databook contains high-level insights into Australia covid-19 vaccine development tools market from 2020 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Australia covid-19 vaccine development tools market size, by technologies, 2020-2028 (US$M)
Australia COVID-19 Vaccine Development Tools Market Outlook Share, 2020 & 2028 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
